Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka
Mohammed Murad Hossain, Associate Professor at National Institute of Cancer Research and Hospital, shared a post on LinkedIn:
“The 2nd Haematology and HSCT Workshop, a two-day (5th and 6th August ) scientific program jointly organized by the Haematology Society of Bangladesh (HSB) and Evercare Hospital, Dhaka, was an outstanding learning experience.
The program was highly interactive, engaging, and full of thought-provoking discussions, practical insights, and stimulating academic exchanges.
It was truly inspiring to see young hematologists from different corners of the country present their topics,ideas and share their knowledge with such confidence and clarity. Their presentations reflected a scientific standard comparable to that of many international meetings.
A special note of appreciation to Professor Abu Jafar Mohammed Saleh Sir for conducting the question-and-answer sessions so skillfully. His enthusiasm, wit, and insightful moderation kept every session lively, interactive, and intellectually enriching.
Congratulations to the organizers, speakers, and participants for making this workshop a memorable academic event. Looking forward to many more such initiatives to advance hematology and HSCT in Bangladesh.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy
-
Sep 20, 2026, 01:04Omar Danoun: Levetiracetam May Increase Thromboembolic Risk With DOACs
-
Sep 20, 2026, 01:02Mohamed Abo-Aly: Which Antiseizure Medication is Safest for Patients on DOACs?